electron microscopy (eM) is the premiere technique for high-resolution imaging of cellular ultrastructure. unambiguous identification of specific proteins or cellular compartments in electron micrographs, however, remains challenging because of difficulties in delivering electron-dense contrast agents to specific subcellular targets within intact cells. We recently reported enhanced ascorbate peroxidase 2 (apeX2) as a broadly applicable genetic tag that generates eM contrast on a specific protein or subcellular compartment of interest. this protocol provides guidelines for designing and validating apeX2 fusion constructs, along with detailed instructions for cell culture, transfection, fixation, heavy-metal staining, embedding in resin, and eM imaging. although this protocol focuses on eM in cultured mammalian cells, apeX2 is applicable to many cell types and contexts, including intact tissues and organisms, and is useful for numerous applications beyond eM, including live-cell proteomic mapping. this protocol, which describes procedures for sample preparation from cell monolayers and cell pellets, can be completed in 10 d, including time for apeX2 fusion construct validation, cell growth, and solidification of embedding resins. notably, the only additional steps required relative to a standard eM sample preparation are cell transfection and a 2-to 45-min staining period with 3,3'-diaminobenzidine (DaB) and hydrogen peroxide (H 2 o 2 ).
IntroDuctIon
Microscopy is an essential cell biology tool that reveals the intracellular locations of specific biomolecules, contributing to the elucidation of their roles in cell structure and function. Fluorescence microscopy is especially powerful because it is rapid and convenient, and an extensive toolbox of fluorescent probes has been developed 1 . Genetically targetable fluorescent protein (FP) tags, in particular, have revolutionized cell biology. However, the spatial resolution of fluorescence microscopy is ~200-300 nm (see Fernandez-Suarez and Ting 2 ), which represents a serious limitation because most biomolecules are much smaller than these dimensions. In recent years, super-resolution fluorescence microscopy techniques have greatly improved upon the resolution of conventional light microscopy, but these techniques require specialized fluorophores and equipment, and they do not yet routinely provide spatial resolution in the sub-10-nm regime 3, 4 . Furthermore, fluorescence microscopy approaches label a specific molecule of interest while failing to highlight the ultrastructural surroundings, limiting their capability to localize the molecule relative to other subcellular structures. Compared with fluorescence microscopy, EM achieves far superior spatial resolution (~1 nm in biological samples 2 ). Moreover, heavy-metal staining of cells before EM reveals the entire cellular ultrastructure, including membranes, large proteinaceous complexes, and subcellular organelles.
Despite its potential, EM of biological samples has been hampered by a lack of tools to label and identify specific proteins of interest. Traditionally, specific proteins are labeled for EM by antibody-based recruitment of an exogenous electron-dense moiety 5, 6 or a catalyst capable of generating EM contrast in situ 7, 8 . However, these approaches require permeabilizing treatments to facilitate reagent entry into cells and the use of mild fixatives to retain antigenicity, both of which lead to less-than-optimal preservation of cellular ultrastructure 9 . Furthermore, antibodies against a particular protein of interest may not be available, and available antibodies often fail to recognize the target in fixed cells or suffer from off-target binding. The Tokuyasu method of ultracryosectioning of sucrose-cryoprotected samples removes the need for permeabilizing reagents, but this approach is technically demanding and requires antibody staining of each individual section 10 . Another approach involves the preservation and imaging of FP signal following high-pressure freezing, freeze-substitution, resin-embedding, and sectioning 11 . Although this approach does not require affinity labeling, it fails to generate an EM-visible label, and its localization accuracy was described as <100 nm and not <10 nm.
Genetic tags offer substantial advantages over antibody-based methods because they do not require permeabilizing treatments. Instead, a gene encoding a tagged fusion construct is introduced, leading to expression of a fusion protein in which the tag is attached to the protein of interest with perfect specificity. The advantages of genetic tags are exemplified by the robust and easyto-use FPs that have revolutionized fluorescence microscopy of biological samples 1 . However, all previous genetically encoded EM probes suffer from major drawbacks that have prevented their widespread adoption. Some tags, such as horseradish peroxidase (HRP), fail to function in most subcellular compartments because they require multiple post-translational modifications 12 , whereas others, such as miniSOG (mini singlet oxygen generator), require intense light exposure, restricting their use to narrow fields of view and making them less straightforward to implement 13 (see ' Comparison of APEX2 with other genetically encoded EM tags' for a detailed discussion).
To overcome the limitations of existing methods, we developed APEX (enhanced ascorbate peroxidase), a genetic tag that generates strong EM contrast in all cellular compartments using Electron microscopy using the genetically encoded APEX2 tag in cultured mammalian cells Although this Protocol focuses on EM imaging in cultured mammalian cells, APEX2 can be used in essentially any cell type, including bacteria 38 , the eukaryotic parasite Giardia lamblia 39 , and yeast 18 , as well as complex tissues and organisms, including zebrafish 14, 28 , Caenorhabditis elegans 19 , Drosophila 40 , and mice 41 . APEX2 is especially useful for EM applications in vivo because, unlike existing genetic tags (see below), APEX2 does not require irradiation with light or exogenous delivery of large molecules such as antibodies and nanoparticles. APEX2 has also been used to label viral proteins after infection of cultured mammalian cells 42, 43 and to study the impact of an infectious intracellular bacterium on ER morphology 29 . It is unclear whether APEX2 can be used in plants, which contain abundant endogenous peroxidases that may create strong background staining 44 .
APEX2 is a multifunctional tag that has been demonstrated for numerous applications beyond EM, including live-cell proteomic mapping 20, 21, [45] [46] [47] , H 2 O 2 -sensing 48, 49 , and fluorescent signal amplification 12, 50, 51 . The multifunctional capabilities of APEX2 enhance its utility for each of its individual applications. For example, in live-cell proteomic mapping studies, APEX2 is targeted to a subcellular region of interest by genetic fusion to a specific protein or peptide, followed by promiscuous 
(d-f) APEX targeted to the nucleus via fusion to a nuclear localization sequence (NLS). (d) COS-7 cells; (e,f) HEK293T cells.
The arrowhead in f points to the nuclear membrane. (g-i) Dimeric APX W41F attached to the plasma membrane, facing cytosol, via fusion to the palmitoylation sequence of GAP-43. Expression in cultured rat hippocampal neurons. The neuronal processes in h appear discontinuous because the neuron is not contained within a single thin section. The arrowhead in i points to an APX-stained plasma membrane. (j-l) APEX targeted to the ER lumen via a KDEL localization sequence in COS-7 cells. The EM images show staining from APEX, whereas the bright-field image shows staining from horseradish peroxidase (HRP). This bright-field image of HRP-stained cells was selected because it clearly demonstrates ER morphology. Similar bright-field results can be obtained with APEX2. The arrowhead in l, which is an enlargement of the red box in k, points to DAB-stained ER. The images shown in k and l are from a sample that was published previously 12 . (m-o) APEX fused to the N-terminal end of the mitochondrial calcium uniporter (MCU), a transmembrane protein of the mitochondrial inner membrane expressed in COS-7 cells. APEX faces the mitochondrial matrix. The arrowhead in o, which is an enlargement of the red box in n, points to APEX staining, which is confined to a subset of sites located between cristae. The images shown in n and o are from a sample that was published previously 12 . (p-r) APEX fused to histone H2B, a chromatin protein in COS-7 cells. (p) The three APEX-stained nuclei exhibit a range of staining intensities because of variability in expression levels with transient transfection. The arrowhead in r points to a nuclear pore complex. APEX staining of chromatin is visible in the nucleus on the left in r. (s-u) APEX2 fused to α-tubulin expressed in cultured rat hippocampal neurons by lentiviral infection. APEX2 is fused to the N-terminal end of α-tubulin and faces the hollow core of the microtubule polymer. (s) A bright-field image after OsO 4 staining and embedding in resin; the OsO 4 staining causes APEX2-negative cells to become slightly dark. (t) A neuron with high APEX2 expression and dark staining is visible. (u) In an enlargement of the red box in t, APEX2-stained microtubules are visible in the dendrite at the center (arrowhead), and microtubules lacking contrast from APEX2 are visible at the top (asterisk). The images shown in t and u are from a sample that was published previously 15 . (v-x) APEX2 fused to β-actin, expressed in cultured hippocampal rat neurons by lentiviral infection. (v) Punctate staining on dendritic spines is visible in a bright-field image after OsO 4 staining and embedding in resin; the OsO 4 staining causes APEX2-negative cells to become slightly dark. (w) APEX2-stained spines are visible along the dendrite at the center. (x) An APEX2-stained spine at high magnification (enlargement of the red box in w), with synaptic vesicles (SVs) visible in the axon on the left. The images shown in w and x are from a sample that was published previously 15 . mag, magnification.
biotinylation of endogenous proteins within a short labeling radius (<50 nm). In these proteomic studies, EM provides critical nanoscale confirmation that the APEX2 fusion construct is properly localized 20, 21 . Conversely, researchers utilizing APEX2 for EM to study a specific protein of interest can use the exact same APEX2 fusion construct to investigate the surrounding proteome. We previously published a Protocol on proteomic mapping using APEX2 (ref. 47) .
Comparison of APEX2 with other genetically encoded EM tags
Among existing genetic tags for EM, APEX2 offers several important advantages. HRP, an enzyme that produces DAB staining by the same mechanism as APEX2, generates excellent contrast as a genetic tag for EM [52] [53] [54] . However, HRP fails to become active in all subcellular compartments outside the eukaryotic secretory pathway because of its requirement for two Ca 2+ ions, nine N-linked glycosylation sites, and four structurally essential disulfide bonds 12 . These critical disulfide bonds form properly only in oxidizing environments with assistance from a suite of protein-folding chaperones 55 . HRP isolated from horseradish retains its activity when injected into the cytosol as a neuronal tracer 56 , indicating that the disulfide bonds of HRP are stable in reducing environments after the protein is folded. However, the inability of HRP to fold outside the secretory pathway causes it to fail as a genetic tag in most contexts, greatly limiting its utility. Furthermore, HRP (44 kDa with glycosylation) is substantially larger than APEX2 (27 kDa), which may increase its potential for perturbation in fusion constructs. Nonetheless, in the subcellular compartments where HRP is active, it is even more sensitive than APEX2 (ref. 15 ), so we recommend testing HRP in parallel with APEX2 for applications within the secretory pathway and on the cell surface (Fig. 2j) . MiniSOG is a genetic tag for EM that converts DAB into an EMvisible polymer in a light-and oxygen (O 2 )-dependent reaction 13 . Similarly to APEX2, miniSOG functions in all compartments of mammalian cells, and miniSOG is smaller than APEX2 (12 kDa versus 27 kDa). The intrinsic fluorescence of miniSOG, caused by its flavin cofactor, facilitates correlated light and EM studies. However, miniSOG is limited by its requirements for intense blue light irradiation and for oxygen gas to be blown on the sample, which make the procedure more complex and allow only one field of view to be stained at a time in a conventional microscopy setup. Furthermore, the requirement for light makes miniSOG incompatible with opaque specimens.
Several other light-dependent genetic tags are available, but they suffer from additional drawbacks. A hybrid chemical-genetic technique called tetracysteine tagging functions by targeting of an exogenous photosensitizer such as the fluorophore ReAsH (resorufin-based arsenical hairpin binder) to a short peptide tag 57 . The small size of the tetracysteine tag is advantageous, but washing away excess unbound ReAsH probe in tissues to reduce background staining can be challenging 58 . GFP has been reported to produce an EM-visible DAB reaction product by a light-dependent mechanism, but the quantum yield of GFP for this process was undetectable, which limits its sensitivity 59 . Metallothioneins have also been reported as genetic tags for EM 60 , but require exogenous addition of heavy-metal salts that are toxic and can induce expression of endogenous heavy-metal-binding proteins, which cause background 61 .
Limitations of the method
Using APEX2 for EM requires the introduction of an exogenous protein tag that is 27 kDa, the same size as GFP, which unavoidably creates a risk of perturbing the endogenous function and/or localization of the protein of interest. Fortunately, APEX2 remains active when fused N-terminally, C-terminally, or internally to a protein of interest, offering multiple options for identifying a nonperturbing fusion construct ('Experimental design'). Although the originally reported APEX tag exhibits weak dimerization at high concentrations in vitro, APEX2 remains monomeric even at concentrations >300 µM (ref. 15) , indicating that APEX2 (b) APEX staining of mitochondria and the nucleus to mark two distinct cell populations. Separate pools of HEK293T cells were transfected with either mito matrix-dimeric APX W41F or nuclear-localized APEX (NLS), lifted, and co-plated into the same dish. (Left) A low-magnification bright-field image of a sample that was embedded and trimmed into a pyramidal shape, immediately before sectioning. The region of interest (arrow) is in the middle of the flat, rectangular region at the top of the trimmed block. (Middle) Higher-magnification bright-field image of the region of interest. Cell 1 lacks APEX staining, cells 2 and 3 contain APEX staining in the nucleus, and cell 4 contains mitochondrial APEX staining. The contrast at the intercellular contact sites between cells 2 and 4, and between cells 3 and 4 (indicated with an asterisk), is not caused by APEX, but instead corresponds to staining from split horseradish peroxidase, a separate EM reporter for intercellular protein-protein interactions 32 . (Right) EM image of the region of interest after sectioning. The sample depicted in this panel was published previously 32 . (c) Correlated bright-field and EM images of a COS-7 cell expressing APEXhistone H2B in the metaphase of mitosis. Cells were fixed using 2% (vol/vol) glutaraldehyde.
is unlikely to induce oligomerization artifacts, especially if the APEX2 fusion construct is expressed at low levels.
APEX2 produces an enzymatic DAB reaction product, which could potentially spread beyond the dimensions of the protein of interest. However, we 12 and others 14 have found that the APEX2 reaction product diffuses minimally when cells are well preserved using strong aldehyde fixation and when the DAB staining is brief and performed at 4 °C. Although antibody-based techniques label the protein of interest with nanoparticles of defined dimensions, resulting in EM contrast that cannot spread, the antibodynanoparticle conjugates themselves have dimensions >10 nm, which inherently limits the resolution. The requirement for the exogenous labeling reagents, DAB and H 2 O 2 , is an unavoidable aspect of APEX2 staining, but these reagents diffuse readily into cultured cells and even complex tissues 14, 19, 28, 40, 41 , indicating that reagent delivery should not limit the application of APEX2 in most systems. Another drawback inherent to APEX2 is that the electron-dense DAB reaction product can potentially obscure endogenous contrast from the labeled structure and its immediate surrounding environment.
APEX2 requires a heme cofactor for activity. Fortunately, most organisms from bacteria to humans produce the form of heme, 'heme b', required by APEX2 for activity. In virtually all cell types tested to date, APEX2 has produced detectable activity, indicating that heme was incorporated into the APEX2 active site from endogenous sources. However, there may be cell types or physiological circumstances in which heme biosynthesis is limited, in which case APEX2 will be inactive unless exogenous heme is supplied.
We have widely observed that EM staining by APEX2 is less sensitive than fluorescence-based detection. This lower sensitivity is inherent to EM because EM provides only one 'color'. Many endogenous cellular structures are visible after heavy-metal staining, and high levels of APEX2 staining are required for detection above this endogenous background. Fluorescence techniques, on the other hand, produce a bright signal exclusively on the cellular target of interest. As a result, APEX2 in some cases produces clear signal using fluorescent substrates but fails to show contrast by EM. We note, however, that the EM visibility of the endogenous ultrastructure also represents an advantage of EM imaging, as it allows the protein of interest to be visualized relative to other cellular structures.
Experimental design APEX2 construct design. Several APEX2 constructs for mammalian expression are available through Addgene, including APEX2 constructs localized to the cytosol, a variety of mitochondrial subcompartments, and the ER membrane (facing cytosol), along with APEX2 fusions to cytoskeletal proteins (tubulin, actin, and vimentin) and Connexin43-GFP-APEX2, which is a useful cloning template for correlated fluorescence and EM (see Reagents section for a full list of APEX2 constructs available on Addgene).
New APEX2 constructs are typically prepared by appending APEX2 to a targeting peptide (for localization to a particular organelle)
Box 1 | Amplex UltraRed labeling • TIMING 1 h
Amplex UltraRed is an extremely sensitive fluorogenic peroxidase substrate that can be used to detect low levels of APEX2 activity within cells 12, 15 . Peroxidases catalyze the H 2 O 2 -dependent conversion of Amplex UltraRed into a derivative of resorufin, a bright red fluorophore. In cases in which it is unclear by light microscopy whether DAB staining is successful, Amplex UltraRed labeling is useful to clarify whether APEX2 activity is absent or present at low levels. The most rapid and sensitive procedure for Amplex UltraRed labeling is to submerge living cells in an ice-cold solution of Amplex UltraRed containing H 2 O 2 , followed by a brief wash and imaging of the live cells. At temperatures close to 0 °C, a large amount of fluorescent product remains trapped inside the cells, leading to extremely sensitive fluorescence detection of APEX2 activity in individual cells. It is critical to stain negative-control cells lacking APEX2 and compare the fluorescence intensities, as some background fluorescence is visible in cells lacking APEX2. The detailed steps for this procedure are as follows: 1. Prepare 10 mM aliquots of Amplex UltraRed in DMSO according to the manufacturer's instructions. Store them at −20 °C and protect them from light. The aliquots may be stored for at least 12 months. 2. Immediately before the experiment, thaw an aliquot of Amplex UltraRed at room temperature, and then dilute to a concentration of 50 µM using cold DPBS and add H 2 O 2 to a concentration of 10 mM. 3. Remove the cells plated on a 48-well plate from the incubator and immediately place them on ice. Incubate the cells on ice until the temperature of the medium has equilibrated (~3-5 min). 4. Gently remove the medium by aspiration and replace it with 200 µl of ice-cold 50 µM Amplex UltraRed solution with H 2 O 2 . 5. After ~2-15 min, gently remove the Amplex solution by aspiration and replace it with fresh ice-cold DPBS. A range of labeling times can be tested for new constructs. For confluent cultures with high transfection efficiencies, the cells sometimes appear pink to the eye, and the solution above the cells may also turn pink because of fluorescent product leaking out of the cells. 6. Image the living cells using a fluorescence microscope (excitation 490-550 nm; emission 580-590 nm). It is acceptable to wait up to ~10 min before imaging, but cells should be kept on ice before imaging to minimize resorufin leakage from cells. ? trouBlesHootInG It is also possible to proceed to cell fixation and immunostaining after these procedures, allowing APEX2 expression and activity to be visualized simultaneously. Formaldehyde fixation, methanol permeabilization, and immunostaining can be performed as described previously 47 . After fixation and permeabilization, bright Amplex UltraRed fluorescence remains trapped inside the cells with a localization pattern matching the subcellular compartment in which APEX2 was expressed. Note, however, that the fluorescence diffuses away from the site where APEX2 is located to completely fill the subcellular compartment. For example, if APEX2 is localized to the plasma membrane and facing the cytosol, the fluorescence signal will fill the entire cytosol, even after cell fixation and washing. or a specific protein via a flexible ~10-aa linker. Detailed guidelines for design of APEX2 constructs can be found in the next paragraphs. We note that Parton and co-workers recently published an alternative APEX2 targeting strategy of appending APEX2 to a GFP-binding peptide (GBP) and then introducing this chimera into cells already expressing a GFP fusion construct 14 . A potential concern with this GBP approach is off-target binding, which could lead to nonspecific EM staining, but Parton and co-workers demonstrated good specificity for several subcellular targets. This APEX2-GBP approach should prove useful for screening the localization of proteins in existing GFP-fusion cell lines.
For the design of new APEX2 constructs, we recommend making fusion constructs with APEX2 (ref. 15 ) over both the original APEX (ref. 12 ) and wild-type ascorbate peroxidase (APX) because of its monomericity, superior catalytic activity, resistance to H 2 O 2 -induced inactivation, and efficiency of heme incorporation within cells 15 . For applications in the eukaryotic secretory pathway and on the cell surface, we recommend testing both HRP 52, 53 and APEX2. HRP (Addgene, cat. no. 44441) does not become active outside the secretory pathway 12 , but within the secretory pathway; HRP is more catalytically active than APEX2 and generates stronger staining 15 . On the other hand, HRP is a 44-kDa glycoprotein that is larger than APEX2 (27 kDa) and hence may be more perturbing in some cases. It is therefore difficult to predict which tag will perform better within the secretory pathway, which is why we recommend testing both.
Search the literature to determine whether the protein or peptide of interest tolerates fusion of genetic tags at specific sites. It is preferable to find literature precedence indicating that attachment of large tags, such as GFP, is tolerated. Avoid fusion to sites where genetic tags have been shown to perturb the protein of interest. If literature precedent is unavailable, fuse APEX2 to the N or C terminus of the protein of interest, or internally within a long, flexible loop region that is not essential for protein function. APEX2 is active as an N-terminal, C-terminal, or internal fusion. The N and C termini of APEX2 are very close to each other (~5 Å apart, based on crystal structures of APX, the enzyme from which APEX2 is derived 62, 63 ), which means it is feasible to fuse APEX2 internally within a short loop region of a protein of interest without perturbing its structure. If the protein of interest contains an N-terminal targeting sequence that is post-translationally cleaved by proteolysis, ensure that APEX2 is positioned C-terminally to the cleavage site. If multiple candidate insertion sites are identified, we recommend testing multiple APEX2 fusion constructs, as it is difficult to predict which one(s) will perform best. Include long, flexible linkers separating APEX2 from the protein of interest, and for internal insertion constructs include linkers on both
Box 2 | Embedding and sectioning of cells as a pellet instead of a monolayer • TIMING 5-6 d
Processing cells as a pellet as opposed to a monolayer may be preferred because it is less technically demanding to cut thin sections of the much thicker pellet. In addition, for cells that grow as a suspension, it may be necessary to process the cells as a pellet. The protocol for embedding and sectioning cells as a pellet is very similar to the main Procedure for cell monolayers. Exactly the same reagents are used, but there are some slight differences in amounts and method of application to the cells. This box provides a stepby-step protocol for processing of cells as a pellet. The steps below serve as a substitute for Steps 10-35 of the main Procedure. We reference extensively specific steps of the main Procedure while highlighting the differences. 1. Follow the instructions of Step 10 of the main Procedure, except plate the cells on any convenient growth surface, such as a well of a six-well plate. To ensure that sufficient cells are plated to generate a large pellet after scraping, we recommend plating cells in two wells of a six-well plate in the case of HEK293T cells (growth area = 9.5 cm 2 per well). Pipette a cell suspension into each well. The volume of cell suspension added to each well should be 2-3 ml, and the density of cells within the suspension should be optimized based on desired timing and confluency for transfection. 2. Once the cells are sufficiently confluent, transiently transfect them (including replicate wells) as described in Step 11 of the main Procedure, but scale up the amounts of transfection reagent and DNA to match the larger volume in the wells. 3. Fix and stain the cells using the exact same reagents outlined in Steps 12-19 of the main Procedure. The only difference is that larger volumes of each solution will be required to completely cover the larger cell growth surface. We typically use at least 1.5 ml of each staining and washing solution per single well of a six-well plate. 4. After the last wash with water (corresponding to Step 19 of the main Procedure), gently remove the water by aspiration and replace it with ~500 µl of fresh water. Use a cell scraper to gently scrape the cells from their growth surface. Ideally, the cells should roll off the plastic in large sheets. Use a razor blade to cut off the end (~2 mm) of a 1,000-µl pipette tip, and then place this truncated tip onto a Pipetman and gently pipette the detached cells into a 1.5-ml Eppendorf microcentrifuge tube. The cell suspensions from the two wells should be combined into a single tube at this point. termini of APEX2. We always include linkers that are at least 10 aa long, such as KGSGSTSGSG or GGGGSGGGGS. If an even longer linker is required, the two 10-aa linkers listed above may be concatenated into a single 20-aa linker. We have not observed any deleterious effects from including a variety of additional 2-to 3-aa motifs (for cloning purposes) on either terminus of the flexible linker.
We strongly recommend attaching an epitope or FP tag in tandem with APEX2 to facilitate characterization of expression levels. Small 10-to 20-aa epitope tags are less likely to perturb the protein of interest than are FPs. We prefer the V5 epitope tag (GKPIPNPLLGLDST) because the mouse anti-V5 antibody from Thermo Fisher Scientific (cat. no. R960-25) enables highly sensitive detection by immunofluorescence. We also often use the FLAG epitope tag (DYKDDDDK). Although the V5 and FLAG epitope tags contain lysine residues, which could potentially react with aldehydes during fixation, these tags retain antigenicity when cells are fixed using formaldehyde before immunostaining, following our published procedure 47 . We have not examined whether these epitope tags retain antigenicity after fixation with glutaraldehyde. The HA epitope tag (YPYDVPDYA) should be avoided because APEX2 can cause oxidative damage to tyrosine residues. In contrast to small epitope tags, FP tags enable convenient visualization in living cells without the need for cell fixation and immunostaining. This capability can be indispensable for time-coursecorrelated light microscopy-EM studies. However, the large size (>54 kDa) of the combined FP-APEX2 fusion increases the likelihood of perturbation of the protein of interest, so the localization of the tandem FP-APEX2 fusion should be compared with that of a non-FP fusion construct whenever possible. A flexible 10-aa linker should be included between the FP and APEX2. An alternative strategy is to link the APEX2 fusion construct to an FP via a self-cleaving P2A peptide 64 , leading to whole-cell fluorescence in transfected cells without increasing the size of the APEX2 fusion to the protein of interest. We note that a chicken IgY antibody against APEX2 has been produced and can be requested from Innovagen. This antibody enables expression of APEX2 to be visualized even in constructs lacking an additional epitope tag.
For cultured mammalian cells, we recommend initially cloning the construct into pcDNA3 (or a similar plasmid) because it drives high protein expression under the cytomegalovirus promoter. Other promoters may be necessary depending on the cell type. We recommend transient transfection for preliminary experiments because it enables fast and convenient evaluation of multiple fusion constructs. If transient overexpression produces strong DAB staining, but also displays evidence of mislocalization, it is worthwhile to test that same construct under more physiologically appropriate expression levels, as improper localization may be an artifact of overexpression. Promising constructs can be introduced at lower expression levels using several different strategies. One approach is to transiently transfect the construct under a weaker promoter. Another option is lentiviral infection 65 , which stably integrates the construct DNA into the cell genome, resulting in controlled levels of expression in a very high percentage of cells. APEX2 produces easily detectable DAB staining in a variety of contexts when introduced at low expression levels by lentiviral infection 15 . Note that, in our experience, lentiviral infection can produce a wide range of APEX2 staining intensities within a single sample, as shown in Figure 2s and v. In an ideal experiment, the construct should be introduced by knock-in to cells lacking the endogenous protein.
Validating APEX2 constructs by light microscopy The DAB reaction product generated by APEX2 can be visualized using light microscopy. We advise validating constructs by light microscopy before proceeding to EM because EM sample preparation is more labor-intensive and time-consuming. In our experience, APEX2 staining that can be detected by bright-field microscopy can always be detected by EM. Overstaining with DAB/H 2 O 2 can potentially damage the cellular ultrastructure in some contexts
Box 3 | Heme supplementation • TIMING 1-17 h
The heme b cofactor required for APEX2 activity is produced endogenously in most organisms ranging from bacteria to humans to plants to yeast. It is therefore not necessary in most cases to supplement heme exogenously. However, there may be cell types in which endogenous heme levels are too low to drive high heme occupancy in heterologously expressed APEX2, and supplementation of exogenous heme may boost DAB staining intensity in these cases. If you are convinced that the APEX2 construct is expressed and has not been truncated by proteolysis (as determined by western blotting), but fails to produce staining (while a positive-control APEX2 construct in another cell type does produce staining), it is worthwhile to try heme supplementation. The detailed procedure is as follows: 1. Prepare a 483 µM heme stock solution. Add 6.3 mg of hemin chloride and 20 ml of 0.01 M sodium hydroxide solution to a 50-ml conical tube. Vortex thoroughly until all of the solid has dissolved. 2. Filter-sterilize the solution using a 0.22-µm filter  crItIcal step Prepare the solution immediately before use. Do not store this solution. 3. Dilute the heme into the appropriate medium to your desired final concentration. Test concentrations range from ~0.5 to 7 µM.  crItIcal step If the medium contains serum, we have found these concentrations of heme to be nontoxic to cultured mammalian cells, including dissociated rat hippocampal neurons 32 . However, if your medium lacks serum, the toxicity of heme at these concentrations should be reassessed. 4 . Submerge the cells in prewarmed heme-containing medium. Allow them to incubate for 0.2-16 h. Heme incubation time should be optimized for each cell type and construct. In general, incubating with heme for longer than 16 h does not lead to further improvement in APEX2 staining intensity.  crItIcal step Heme supplementation can substantially increase background staining in some cell types, so it is critical to incubate separate negative-control cells (lacking APEX2) with heme and proceed with an identical staining procedure to check for endogenous background staining. (Fig. 4) , so samples should be stained for the minimum time required to detect the reaction product by light microscopy. The approximate subcellular localization of APEX2 can usually be discerned using bright-field microscopy. Ensure that the DAB staining exhibits no evidence of mis-localization artifacts.
If DAB staining is undetectable by light microscopy, there are many possible explanations, as outlined in the 'Troubleshooting' section. It is important to first confirm that the transfection and DAB staining procedures were performed correctly. If these criteria are met, it is possible that APEX2 is producing DAB reaction product that cannot be seen by light microscopy but would be detectable by EM. To investigate this possibility, we recommend testing for peroxidase activity using either Amplex UltraRed, as detailed in Box 1, or biotin-phenol followed by fluorescently labeled avidin 47 . These fluorescent readouts provide much more sensitive detection of APEX2 activity, often giving positive signal even when DAB staining is undetectable. If these alternative substrates indicate that APEX2 is clearly active under the conditions of the transfection, then it is worthwhile to proceed to EM, even if DAB staining is not detectable by light microscopy.
We additionally recommend immunofluorescence staining of an epitope tag appended to the APEX2 fusion to assess expression levels and localization. When possible, check for colocalization of APEX2 with a trusted marker. We advise expressing the APEX2 fusion as close to endogenous levels as possible while still obtaining detectable DAB staining. In an ideal experiment, the endogenous protein should be replaced by the APEX2 fusion, and a functional assay should be performed to confirm that attachment of APEX2 does not perturb the protein of interest. For example, we confirmed that a fusion of APEX to the mitochondrial calcium uniporter was functional for transporting calcium into the mitochondrial matrix 12 . Claypool and co-workers examined lipid metabolite ratios to confirm the activity of an APEX2 fusion to tafazzin, a transacylase enzyme 24 . Sandin and co-workers showed that an APEX2 fusion to the protein caveolin rescued the formation of caveole 27 .
Cell pellet versus a monolayer of cells for EM experiments.
Once APEX2 constructs are validated by light microscopy, they can be introduced into cultures for EM sample preparation. One must decide at the outset what type of EM sample to prepare: (i) embed and section the cells in situ as a monolayer, or (ii) gently scrape the cells from their growth surface, centrifuge them into a pellet, embed the pellet, and cut thin sections.
Cutting a cell monolayer is more technically demanding, as a monolayer is much thinner than a cell pellet, but sectioning a cell monolayer offers several advantages. First, it enables an individual DAB-stained cell to be identified by bright-field imaging, followed by subsequent correlated EM imaging of that exact same cell (Fig. 3) . The ability to image a monolayer sample by lower-magnification bright-field microscopy before cutting sections is extremely helpful for rapidly scanning a large number of cells to identify the ones with particular morphologies or APEX2 staining patterns. For cell cultures with low transfection efficiencies, an APEX2-positive cell can be identified by light microscopy within the embedded monolayer, followed by cutting of thin sections containing that exact cell, greatly improving the chances of identifying APEX2 staining by EM. By contrast, scraping the cells and generating a pellet prevents any correlation with bright-field imaging. In addition, embedding cells as a monolayer maintains attachments of cells to their growth surface, whereas scraping into a pellet can potentially damage cells and alter adhesion morphology 66 . We do note that processing cells as a pellet is advantageous for cells that grow in suspension. This Protocol will focus on embedding a monolayer of cells, but we also provide a step-bystep guide for embedding a cell pellet, which requires only minor adjustments to the procedure 20,21 (Box 2).
For both experimental approaches, it is essential to incorporate negative-control cells. In transiently transfected cell cultures with transfection efficiencies <100%, APEX2-stained cells can be located immediately adjacent to unstained cells by EM (Fig. 2) . For experiments in which 100% of the cells express APEX2 (for example, when stable cells are used), researchers should prepare a separate negative-control sample using an identical procedure in which the cells express a construct lacking APEX2. Alternatively, negative-control cells could be mixed together with the APEX2 cells in the same culture to avoid the need to process multiple samples.
EM sample preparation: fixation, staining, embedding, and sectioning. In this Protocol, which is specific to cultured mammalian cells, we recommend fixing with 2% (vol/vol) glutaraldehyde because it yields optimal ultrastructural preservation. APEX2 activity also survives fixation with formaldehyde (at least up to 4% (vol/vol)) and acrolein (at least up to 10% (vol/vol)) (data not shown). Researchers should therefore use whichever fixation reagents yield optimal ultrastructural preservation for their particular cell type. APEX2 is likely to retain activity regardless of which aldehyde fixatives are used. We caution that organic solvents such as methanol and acetone should be avoided because they abolish APEX2 activity. To our knowledge, APEX2 has not been tested for compatibility with high-pressure freezing procedures, but APEX2 activity does survive fixation with paraformaldehyde, immersion in high concentrations of sucrose followed by optimal cutting temperature compound, rapid freezing, and cryosectioning (M. Yamagata and J.R. Sanes (Harvard University), personal communication).
After fixation, cells are stained with DAB and H 2 O 2 , which diffuse readily into fixed cells. The concentrations and staining times presented in this Protocol are specific for monolayers of cultured mammalian cells. For thick tissue specimens, higher concentrations and/or longer staining times may be required to facilitate diffusion of DAB and H 2 O 2 into the sample. Some tissue samples contain endogenous peroxidases that generate background DAB staining, and a common procedure to inactivate these peroxidases, thus blocking background staining, is pretreatment with high concentrations of H 2 O 2 . APEX2 should be fully compatible with such preblocking procedures; although APEX2 is inhibited by high concentrations of H 2 O 2 , this inhibition is reversible 15 .
Samples are next stained with OsO 4 , which reacts with the DAB polymer and deposits electron-dense osmium to produce EM contrast. OsO 4 also stains biological membranes and other biomolecules, making this step important for visualization of the ultrastructural context, not just the location of APEX2. After OsO 4 , samples are stained with uranyl acetate to generate additional contrast. As noted in the Procedure section, some groups have used alternative heavy-metal reagents, or omitted heavy-metal staining altogether, and still obtained successful results using APEX2.
After (Fig. 3) . These specific regions of interest are marked, excised using a jeweler's saw, trimmed, and cut into ultrathin sections.
Sectioning for EM requires extensive training that is beyond the scope of this Protocol. For a detailed practical manual, see Bozzola and Russell 67 . For researchers unfamiliar with sectioning, we strongly recommend working with a collaborator or core facility. We suggest clarifying with the microscopist whether he or she is familiar with sectioning cell monolayers and/or cell pellets.
At the end of the Procedure section, we describe the placement of individual thin sections on grids followed by EM imaging. We present detailed guidelines for EM imaging and comparisons with negative-control samples to unambiguously identify contrast generated by APEX2 (Anticipated Results). Within a sealable container, mix the entire 2-ml contents of the ampule with 2.66 ml of 3× sodium cacodylate solution and 3.34 ml of water. Tightly seal the container and place the solution in a 37 °C incubator for 5-10 min to prewarm before addition to cells. Use the solution within 1-2 h after preparation. For samples that will not be processed for EM, it is acceptable to use PBS instead of 1× sodium cacodylate. If fixatives other than 2% (vol/vol) glutaraldehyde are known to yield better ultrastructural preservation in the particular system being studied, then those alternative fixatives may be used-they are likely to work, as APEX2 activity survives formaldehyde, acrolein, and glutaraldehyde. ! cautIon Glutaraldehyde is toxic and should be handled inside a fume If not all of the solid dissolves, centrifuge at 11,000g at room temperature for 10 min to remove the undissolved material. Prepare ten 1-ml aliquots of the resulting solution, flash-freeze the aliquots, and store them at −80 °C. Aliquots can be stored for several months at this temperature. Once an aliquot has been thawed, use it within 30 min and throw away afterward (do not re-freeze). This recipe can be scaled up as needed to make more (or larger) aliquots. Note that DAB tetrahydrochloride and various DAB-containing peroxidase staining kits are commercially available, but we recommend starting with the free base DAB, freshly preparing the tetrahydrochloride, and immediately storing at −80 °C, as described above, to ensure consistency and to minimize degradation of the compound. ! cautIon Some safety data sheets for DAB state that it is suspected of causing cancer. DAB should therefore be handled with caution. Wear full personal protective equipment and treat DAB solid and solutions as hazardous. Add the 2% (vol/vol) glutaraldehyde solution immediately after removal of the medium; residual medium after aspiration is normally sufficient to prevent cells from becoming dry, but do not wait more than 10 s before adding fixative.  crItIcal step Note that for samples that will not be processed for EM, it is acceptable to use PBS, which is nontoxic, in place of 1× sodium cacodylate. See the 'Reagent Setup' section for details.
MaterIals
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• • • • • • • • • • • • • • • • • hood.  crItIcalPrepare this solution freshly before use.  crItIcal An alternative buffer
5|
Remove the 1× sodium cacodylate and add 250 µl of cold (0-4 °C) 20 mM glycine solution (Reagent Setup). Glycine reacts with and quenches unreacted aldehyde functional groups. Incubate for 5 min on ice, and then remove by gentle aspiration and wash three times for 1 min each time in cold buffer.
6|
Prepare a fresh solution containing 1× DAB (0.5 mg/ml) and 10 mM H 2 O 2 , as described in 'Reagent Setup' . Remove the buffer from Step 5, add 250 µl of 1× DAB solution with 10 mM H 2 O 2 , and incubate on ice until a light brown stain is visible under a stereo light microscope (this occurs within 5-45 min). Remove the DAB solution and wash three times for 1 min each time in 1× sodium cacodylate. ! cautIon Many safety data sheets state that DAB is suspected of causing cancer. DAB should therefore be handled with caution. Wear full personal protective equipment and avoid all contact with DAB-containing solutions.  crItIcal step For preliminary construct validation by light microscopy, we recommend staining with DAB for 30-45 min to make the staining very prominent, enabling accurate assessment of the percentage of cells with DAB staining and also the localization pattern. It is also worthwhile at this stage to identify the minimum DAB staining time required to produce signal that is detectable by light microscopy. Staining for too long with DAB can potentially damage cellular ultrastructure in subsequent EM experiments (Fig. 4c) . Note that transient transfection typically produces a range of expression levels, which means DAB staining intensity also varies from cell to cell.  crItIcal step For new constructs and cell types, we recommend testing a range of H 2 O 2 concentrations (from 0.1 to 10 mM) to identify the optimal concentration (Reagent Setup).
? trouBlesHootInG  pause poInt The DAB-stained cells can be stored at 4 °C for up to 12 h without noticeable change to the sample before light microscopy imaging. For longer storage, we recommend storing the cells in buffer containing an antibiotic, such as kanamycin, to prevent microbial growth.
7|
Image the cells, including negative-and positive-control samples, at high magnification (40× or higher) using bright-field microscopy. Take careful note of the percentage of cells exhibiting DAB staining and the pattern of the staining (Fig. 2) . Take note of cell health and cell density.
? trouBlesHootInG 8| (Optional) Perform immunostaining of an epitope tag attached to APEX2, followed by fluorescence imaging to characterize the expression level and to confirm overlay of APEX2 with a trusted marker of the desired subcellular location. See our previously published procedure for details 47 . It is essential to confirm that the APEX2 fusion protein exhibits the same localization pattern as the endogenous, untagged protein of interest. Furthermore, if the APEX2 construct is expressed protocol 1804 | VOL.12 NO.9 | 2017 | nature protocols at higher-than-endogenous levels, the possibility of overexpression artifacts must be kept in mind during subsequent EM imaging, even if the localization pattern appears correct by fluorescence microscopy. We note that a chicken IgY antibody against APEX2 has been produced and can be requested from Innovagen. This antibody enables visualization of APEX2 expression even in constructs lacking an additional epitope tag. 
11|
Introduce the APEX2 construct of interest, validated by Steps 2-9 above, to the cells. For transient transfection, gently remove all of the medium by aspiration (or gentle pipetting, preserving the medium, if necessary), and then add fresh medium containing plasmid DNA and transfection reagents according to the manufacturer's instructions. To conserve reagents, it is acceptable to add only a small volume (~500 µl), enough to cover the cells on the central glass portion of the dish. Return the cells to incubator and incubate for the time recommended by the transfection reagent's manufacturer, and then remove the transfection medium by aspiration and replace with ~2 ml of medium (either fresh or preserved from the earlier culture). For lentiviral infection, the infectious medium or concentrated lentivirus can simply be added to the existing cell culture medium.  crItIcal step Be sure to prepare the appropriate control dishes at this stage. For example, a negative-control dish could be transfected with a plasmid encoding the protein of interest without APEX2 fused to it, and a positive-control dish could be transfected with an APEX2 construct known to produce strong EM staining. 13| After the 60-min fixation, wash the cells five times for 2 min each time in ~1.5-2 ml of cold (0-4 °C) 1× sodium cacodylate buffer while leaving the cells on ice. Washes are performed by gently removing the liquid from the cells by aspirating or pouring, and then gently replacing with cold buffer and allowing cells to incubate on ice. The precise volume used for each wash is not important, as long as the entire dish is completely rinsed, including the entire bottom and sides. It is acceptable for washes to be slightly longer than 2 min.  crItIcal step Proceed immediately to the next step.
14|
Remove the buffer and add 1.5-2 ml of 20 mM glycine in 1× sodium cacodylate (Reagent Setup). Incubate the cells for 5 min on ice, and then remove the 1× sodium cacodylate and wash the cells five times for 2 min each time in 1.5-2 ml of cold 1× sodium cacodylate buffer.
15| (Optional) For researchers wishing to observe fluorescent signal in their samples, perform fluorescence imaging directly after Step 14 because the next step (DAB labeling) may abolish fluorescence.  crItIcal step Keep the sample cold (0-4 °C) at all times during imaging and proceed to the next step immediately after imaging is complete. Samples left on ice for a few hours before heavy-metal staining should exhibit well-preserved ultrastructure by EM, but for optimal ultrastructure preservation it is generally advisable to proceed to the OsO 4 staining step without delay.
? trouBlesHootInG 16| Prepare a fresh solution containing 1× DAB (0.5 mg/ml) and 10 mM (or the optimized concentration as determined in
Step 6) H 2 O 2 in cold (0-4 °C) 1× sodium cacodylate (Reagent Setup). Remove the washing buffer from Step 15 and submerge the cells in at least 2 ml of DAB solution and let them incubate on ice for the optimized length of time determined in
Step 6 (5-45 min). Gently remove the DAB solution and wash the cells five times for 2 min in buffer. The DAB reaction product can be visualized by light microscopy at this stage of the procedure, but it is important to keep the cells cold (0-4 °C) at all times, either by keeping the cells on ice during imaging or by continually exchanging the solution in the dish with fresh ice-cold solution. ! cautIon Many safety data sheets for DAB state that it is suspected of causing cancer. DAB should therefore be handled with caution. Wear full personal protective equipment and avoid all contact with DAB-containing solutions.  crItIcal step Keep the sample cold at all times during imaging and proceed to the next step immediately after imaging is complete. Samples left on ice for a few hours before heavy-metal staining should exhibit well-preserved ultrastructure by EM, but for optimal ultrastructure preservation it is generally advisable to proceed to the OsO 4 4 waste directly to the waste container containing the sodium sulfite quenching solution. Wash the cells five times for 2 min with 1.5-2 ml of ice-cold water, and transfer the waste from the first wash directly to the waste container containing the sodium sulfite quenching solution. ! cautIon OsO 4 is a highly reactive and harmful substance. Wear full personal protective equipment and avoid all contact with OsO 4 -containing solutions. OsO 4 is a volatile compound that generates harmful and reactive vapors, so it must be kept inside a properly functioning fume hood at all times before quenching.  crItIcal step It is critical to avoid staining with OsO 4 before the DAB labeling because OsO 4 is very likely to abolish APEX2 activity.  crItIcal step Some studies have indicated that OsO 4 concentrations <2% (wt/vol) yield optimal results for their purposes 14 . The 'reduced OsO 4 ' procedure, which involves addition of 1% (wt/vol) potassium ferrocyanide immediately prior to staining and produces stronger contrast on membranes relative to other cellular components, has also been used for staining DAB reaction product from APEX2 (refs. 23,24) . Finally, Joesch et al. reported that reducing tissue samples using sodium hydrosulfite before OsO 4 staining greatly enhances the EM-level contrast of APEX2 staining 41 .  crItIcal step After OsO 4 staining, the APEX2 reaction product generally appears darker by bright-field microscopy, but cells lacking APEX2 may also appear slightly dark ( Fig. 2s and v) .
18|
Remove the water and submerge the cells in 1.5 ml of cold (0-4 °C) 2% (wt/vol) uranyl acetate solution. Incubate the cells at 4 °C in the dark for 1-20 h. ! cautIon Wear full personal protective equipment and avoid all contact with uranyl-acetate-containing solutions. Uranyl acetate produces mild levels of radioactivity that are not sufficient to be harmful when the compound remains external to the body, but are very harmful if uranyl acetate is ingested.  crItIcal step Uranyl acetate solutions should be protected from light as much as possible, both before and after addition to cells, to avoid the formation of unwanted precipitates.  pause poInt It is possible to store or transport samples overnight at this stage while still maintaining good ultrastructure preservation. To do this, fill the dish to the top with cold uranyl acetate solution, place a sheet of stretched Parafilm over the top (ensure there are no bubbles to avoid sloshing), press the Parafilm firmly around the edges of the dish to create a seal, place the plastic lid on the dish, and seal with additional Parafilm. Gently invert the sealed dish to ensure that there are no leaks or bubbles. Seal the dish in a plastic bag filled with wet ice, and then store the samples at 0-4 °C or ship them overnight in an insulated container filled with soft packaging.
19|
Remove the uranyl acetate and wash the cells five times for 2 min each time with 1.5-2 ml of cold water. ! cautIon Aqueous 2% (wt/vol) uranyl acetate solution should be treated as hazardous waste.  crItIcal step Wash the dish with excess liquid, completely covering the entire dish, including the sides, not just the central portion containing cells. Make sure that at the completion of the washes no yellow color is present in the discarded water. 
21|
Dehydrate the cells by sequentially placing them for 2 min into at least 2 ml of each of the following ice-cold solutions (in this order): 20, 50, 70, 90, and 100% (vol/vol) ethanol. For the 100% (vol/vol) ethanol, use a freshly opened bottle of ultrapure ethanol without any trace of water.  crItIcal step It is important to completely wash out the solution from each prior step. Be very careful to never let the cells become dry. Allowing the cells to become dry can severely damage the ultrastructure.  crItIcal step Avoid propylene oxide and acetone during dehydration because they can dissolve MatTek dishes.
22|
Move the cells to room temperature, replace the ethanol with at least 2 ml of room-temperature 100% (vol/vol) ethanol, and incubate the cells for at least 2 min.  crItIcal step Be very careful to avoid letting the cells become dry because this severely damages the cellular ultrastructure. The 100% (vol/vol) ethanol will evaporate quickly, especially at room temperature. 24| Remove the ethanol/resin mixture and dispose of it directly into a properly labeled chemical waste container. Immediately add ~2-4 ml of pure Durcupan resin (prepared in Step 20) . The resin should be similar in viscosity to glycerol. We recommend dispensing the resin by using a plastic dropper with the tip cut off. The resin should fill about one-quarter of the dish's volume, and the precise volume is not important, as long as it exceeds 2 ml. Place the dish on a rocking plate, with the plastic lid covering the dish, at room temperature for 1-2 h. It is normal to see bubbles in the resin, which will disappear later when the sample is placed in the oven.
25|
Remove as much resin from the dish as possible by pouring it into a waste container and scraping residual resin out of the dish using a rubber policeman. Add ~2-4 ml of fresh resin and place the dish on a rocking plate at room temperature for 1-2 h.  crItIcal step It is critical to remove as much of the resin as possible to completely remove all ethanol. Otherwise, polymerization may fail, resulting in plastic that is too soft for cutting good sections, especially in the area immediately surrounding the cells. Do not worry about the cells becoming dry at this stage because a small amount of resin always remains stuck to the cells.  crItIcal step Never touch the cells with the rubber policeman. This will scrape the cells off the dish. Instead, only scrape the rubber policeman on the peripheral portions of the dish that do not contain cells.  crItIcal step Durcupan resin waste can be allowed to polymerize at 60 °C for several days, after which time it can be disposed of as nonhazardous waste.
26|
Repeat the previous step.
27|
Carefully remove as much resin as possible and replace with ~2 ml of fresh resin, such that the imaging dish is approximately one-quarter full. Wipe residual resin from the sides of the dishes and cover the dishes with their plastic lids. Place the dishes in a 60 °C oven on a flat surface for 48 h.  crItIcal step Ensure that the oven is not colder than 60 °C; otherwise, the plastic produced at the end of the polymerization might be too soft.  crItIcal step Do not fill the dish to more than one-quarter full; otherwise, the polymerized plastic will be too tall and will require inconvenient additional trimming later in the procedure.
28|
After 48 h, remove the dishes from the oven and let them cool to room temperature. Remove the plastic lids by firmly twisting and/or compressing the lids (it is normal to hear a cracking sound when detaching the lid from the dish). Press a fingernail firmly against the resin. It should not be possible to dent the solid plastic at room temperature. If your fingernail creates a dent after the sample has cooled to room temperature, this means that the plastic is not hard enough to cut good sections.
? trouBlesHootInG  pause poInt The samples are stable indefinitely at room temperature once they are embedded in resin.
29| Examine the embedded dish by bright-field microscopy to identify regions of interest that contain APEX2-stained cells (Figs. 2s,v and 3) . If warranted, take pictures of interesting cells, taking careful note of their location on the dish. Mark regions of interest on the embedded dish by gently touching a thin Sharpie marker to the plastic, creating a 'dot' that can be identified later.  crItIcal step From this point forward, nonspecialists should transfer their samples to an electron microscopist skilled in trimming and sectioning.
sectioning and eM imaging • tIMInG 1 d 30| Cut out the area of interest from the embedded dish using a jeweler's saw. The size of the excised region should be ~5 mm × 5 mm. To excise, secure the embedded dish within a fume hood using a vise such that the dish protrudes from the top of the vise, with the region of interest visible. While maintaining a continuous sawing motion throughout the process, guide the saw blade to create a rectangular outline of the region of interest, with one cut on each side. Apply gentle pressure with a thin object to remove the region of interest from the dish. ! cautIon Perform all sawing inside a fume hood to avoid inhalation of plastic dust. Wipe all dust from the excised plastic before removing it from the hood. ! cautIon The excised region of resin sometimes comes off the block with high velocity. Wear eye protection at all times while sawing. Keep the space around the vise free of clutter so that the excised region is easy to locate after it is removed.
31| Mount the excised plastic region onto a dummy block using cyanoacrylic glue, with the glass coverslip opposite the dummy block. This is achieved by covering the non-glass side of the excised plastic cube with a thin layer of cyanoacrylic glue, and then firmly pressing it into the flat surface of a dummy block for at least 10 s.
32|
Remove the glass coverslip from plastic region of interest. This is achieved by securing the dummy block on an ultramicrotome in the manual block trimming configuration, with the glass coverslip of the embedded sample pointing up. Dispense a small drop of water directly onto the glass coverslip using a syringe with a 0.22-µm sterile filter on the outlet, such that water completely covers the glass coverslip. Position a razor blade under a corner of the glass coverslip, with the blade plane offset by ~10° from the plane of the glass slip. Apply gradually increasing force to the glass coverslip to pry it from the plastic. Maintain a steady force while water flows under the glass. In some cases, the entire glass slip can be removed in one piece. In other cases, the glass will break, leaving a part of the plastic exposed and pieces of glass still on top of the block. If this happens, use compressed air to clear the block of residual glass and water, dispense fresh water from the sterile filter syringe onto the glass, and systematically continue to remove the glass in sections from the edges until no glass remains on the top of the block.  crItIcal step Never directly touch the plastic block with the razor blade. This will damage the top portion of the block, which is the critical thin layer that contains the cells.
? trouBlesHootInG 33| Use a combination of rough trimming (with a razor blade) and fine trimming (using an ultramicrotome and glass knife) to generate a pyramid-shaped block, with a square, rectangular, or trapezoidal block face surface with dimensions of ~1 × 1 mm. See Figure 3b for an example of a properly trimmed block. During trimming, periodically examine the top face of the block under a stereomicroscope to ensure that the DAB-stained region of interest remains close to the center of the remaining material.
34|
Ensure that the block is oriented perfectly parallel to the diamond knife blade and that the reservoir next to the knife edge is filled with water to the proper level. Cut ~10-15 thin sections (with 60-to 80-nm thickness) from the block. The sections should float on the water and gradually move away from the knife edge as additional sections are cut. Keep the block mounted on the ultramicrotome in case you did not cut deep enough into the cells.  crItIcal step Sectioning with an ultramicrotome is an advanced technique that requires extensive training. Researchers not already familiar with this technique are advised to work with a collaborator or core facility to perform the sectioning. We do not provide a comprehensive tutorial for sectioning, but simply highlight a few important technical considerations. An excellent, detailed guide on sectioning technique is provided by Bozzola and Russell 67 .
35|
Using biology-grade anti-capillary tweezers, carefully use a grid and lift the sections from the water in the knife trough, so that they lay flat on the grid. Carefully dry the grids using a wedge of clean Whatman no. 1 filter paper and place them into a grid box.  crItIcal step Never touch the filter paper directly to the section.  crItIcal step Post-section staining is not necessary. All of the images in the figures were obtained without post-section staining. If desired, standard to light on-grid staining with uranyl acetate and/or lead citrate may be used 25, 31 .
In most cases, post-section staining will not obscure the APEX2 reaction product.  pause poInt Samples can be stored in the grid box indefinitely at room temperature before imaging.
36|
Place the grid in the specimen holder of a TEM. Scan across the grid at low magnification (500-1,000×) initially, at a voltage of 80 keV. If a region of interest is identified at low magnification, maintain focus at low magnification for a few seconds, and then increase the magnification. Imaging a fresh portion of the section at high magnification can disintegrate the section, but brief exposure to the electron beam at low magnification causes the section to stabilize, making it more resistant to degradation upon subsequent high-magnification imaging. Before proceeding to EM, APEX2 constructs should be fully validated by light microscopy to confirm good activity, reasonable expression levels, and proper localization (Fig. 2) . The shortest possible DAB staining time that yields clear contrast by bright-field microscopy should be used. In our experience, nearly all APEX2 fusion constructs produce DAB staining by light microscopy. If DAB staining is not visible, Amplex UltraRed labeling can reveal whether the APEX2 construct is active at levels that are not detectable by light microscopy, but potentially visible by EM (Box 1). Immunofluorescence should be performed to characterize the expression level of the APEX2 fusion construct and to confirm that the construct overlays with a trusted marker. If the initial APEX2 fusion construct fails validation by light microscopy, the construct should be reconfigured and retested (Experimental design).
Bright-field imaging results should be used for guidance in determining the number of fields of view that must be examined by EM. For example, if only 5% of cells exhibited DAB staining that was detectable by bright-field microscopy, then in general at least 20 cells must be examined to discover 1 cell with APEX2 staining, and at least 100 cells must be examined to discover 5 cells with APEX2 staining. If some of the APEX2-stained cells appear unhealthy or exhibit poor ultrastructural preservation, then an even greater number of fields of view must be examined in order to identify at least 5 well-preserved and healthy APEX2-positive cells. It is possible for APEX2-stained cells to appear unstained by bright-field microscopy yet exhibit contrast by EM, but if >200 cells have been examined by EM from multiple thin sections without discovery of APEX2 staining, it is advisable to prepare a new sample that exhibits clear contrast by bright-field microscopy.
electron microscopy data interpretation
Before claiming that an APEX2 fusion construct exhibits a particular subcellular localization by EM, one must establish that this localization is consistently observed across several fields of view. As with any type of imaging, a single field of view can be misleading. It is critical to carefully compare APEX2-stained cells with untransfected cells so that authentic APEX2 staining can be distinguished from endogenous background (Fig. 2) . If untransfected cells are present within the same sample as APEX2, capture as many images as possible (ideally >5) containing both APEX2-stained and APEX2-negative cells within the same field of view. Very subtle staining can be difficult to discern; it is preferable to find cells with APEX2 staining that is clearly stronger than the endogenous background. For example, mitochondria in untransfected cells often appear dark by EM after staining with DAB and H 2 O 2 , probably a result of endogenous redox proteins generating small amounts of DAB polymer. For an example, see Figure 2l , in which the mitochondrion at the lower left is not stained by APEX but nonetheless appears darker than the surrounding cytosol (although not as dark as the APEX-stained ER lumen). In our experience, the intensity of endogenous protocol nature protocols | VOL.12 NO.9 | 2017 | 1815 mitochondrial staining can vary depending on cell type and experimental conditions. Therefore, to demonstrate convincing APEX2 localization to mitochondria, one must capture images of mitochondria that are clearly stained more strongly than endogenous mitochondria under matched experimental conditions. In another example, APEX2 staining may not even be apparent for constructs with diffuse cytosolic localization unless an APEX2-stained cell is imaged next to an untransfected cell.
If negative-control cells are not present in the same sample as APEX2 cells, one must be cautious in comparing staining intensities across multiple images. Many EM image acquisition programs automatically scale contrast, so contrast levels are not necessarily matched across multiple fields of view. We recommend calibrating contrast levels between separate fields of view such that some distinctive endogenous feature, such as the plasma membrane, ribosomes, or chromatin, appears equally dark. This adjustment will approximately match the contrast levels.
Throughout EM imaging, check for abnormalities in cellular ultrastructure, such as disrupted membranes, aggregated organelles, or other perturbations to cell morphology (Fig. 4) . If an abnormality is observed in both transfected and untransfected cells, then the problem is probably caused by poor fixation or another issue with sample preparation (see 'Troubleshooting' section). If the abnormality is specific to APEX2-stained cells, then the APEX2 construct may be perturbing the cells. One possibility is that overexpression of the APEX2 fusion construct may perturb cellular ultrastructure and/or make cells sick. Note that strong overexpression of APEX2 tethered to some membranes, such as the mitochondrial outer membrane or ER membrane (facing cytosol), can potentially induce abnormal aggregation of the compartments 15 . Perturbations to cellular ultrastructure may not necessarily be caused by APEX2, but instead could be caused by overexpression of the protein to which APEX2 is appended. Another potential problem is that APEX2 staining might be too strong, which can rupture membranes and damage subcellular organelles (Fig. 4) .
Even if the cells appear healthy and normal in terms of ultrastructure, check for potential artifacts in localization of the APEX2-stained protein. If APEX2 localization is inconsistent with literature reports for the protein of interest, it is possible that the APEX2 fusion is improperly localized-although it is also possible that the literature reports are incorrect 12 . If APEX2 is fused to a protein that incorporates into a filament or macromolecular complex, ensure that the size of the APEX2-stained structure is consistent with published dimensions. For example, vimentin-APEX2 exhibits staining on intermediate filaments ~10 nm in thickness 12, 14 , consistent with prior reports.
APEX2 staining does not cross membranes, which makes it useful for determining the topology of transmembrane proteins 12, 21 . Membranes react with OsO 4 , which gives them strong contrast by EM, so it can sometimes be difficult to discern the boundary between a membrane and APEX2 staining. Examining the entire length of the membrane within the field of view can facilitate its identification. If by chance the thin section was cut parallel to the plane of a membrane, it will usually not stand out as clearly by EM, so additional imaging may be necessary to identify a clearer field of view.
APEX2 staining may in some cases outline the structure of macromolecular complexes. For example, we found that Connexin43-APEX2 staining within gap junctions matched the dimensions of the hexameric Connexin complex 12 . This analysis was facilitated by 3D tomography, which may not always be possible, but even in single images of thin sections it is often possible to discern periodic structures. One should not assume APEX2 to be capable of outlining individual protein complexes with single-nanometer resolution, considering that APEX2 itself is 4 nm in size, and the DAB polymer can spread beyond these dimensions. coMpetInG FInancIal Interests The authors declare competing financial interests: details are available in the online version of the paper.
